Point-of-care testing in hospitals and primary care.

BACKGROUND Many medical laboratory tests can now be done near the patient (point-of-care testing, POCT), ranging from basic blood glucose measurement to complex coagulation testing. Switching from conventional laboratory testing to POCT shortens the time to decision-making about further testing or treatment, as delays are no longer caused by specimen transport and preparation, and the test results are rapidly available at the point of care. Better medical outcomes and lower costs may ensue. METHOD Selective literature review. RESULTS The available methods and equipment enable persons not specially trained in laboratory medicine to perform high-quality laboratory testing at the point of care, under certain conditions. Before POCT is introduced in a hospital or outpatient practice, a cost-benefit analysis should be performed, because the introduction is costly and requires a certain amount of organizational work especially for quality management. The potential medical and economic benefits should be assessed individually in each case. CONCLUSION POCT for certain applications is a useful complement to conventional laboratory testing. The future utilization of POCT will depend not only on technical advances, but also on developments in costs and reimbursement.

[1]  T Lauritzen,et al.  Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. , 1999, Clinical chemistry.

[2]  P. Luppa,et al.  Die Bilirubinbestimmung – Eine aktuelle Übersicht / Bilirubin measurement – An updated survey , 2008 .

[3]  P. Luppa,et al.  Online-Qualitätssicherung patientennaher Sofortdiagnostik (Point-of-Care-Testing) unter Nutzung des Kommunikations-Systems des Krankenhauses / Online quality assurance of point-of-care testing by using the hospital information system , 2004 .

[4]  H. Schlebusch,et al.  Patientennahe Laboratoriumsdiagnostik (Point-of-Care Testing) , 1998 .

[5]  M. Elam,et al.  Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. , 2000, Journal of the American Pharmaceutical Association.

[6]  C. Price Point of Care Testing in Haematology. , 1998, Hematology.

[7]  A multicentre study of the new Reflotron system for the measurement of urea, glucose, triacylglycerols, cholesterol, gamma-glutamyltransferase and haemoglobin. , 1988 .

[8]  Larry J Kricka,et al.  Improving healthcare accessibility through point-of-care technologies. , 2007, Clinical chemistry.

[9]  Rainer Haeckel,et al.  Qualitätssicherung der patientennahen Sofortdiagnostik (Point-of-Care-Testing) im Krankenhaus: Muster für eine hausinterne Richtlinie / Quality assurance in bedside testing at the hospital: sample guidelines for internal use , 2004 .

[10]  Peter B. Luppa,et al.  POCT - Patientennahe Labordiagnostik , 2008 .

[11]  Gerd Hafner,et al.  Patientennahe Bestimmung natriuretischer Peptide Near-patient testing of natriuretic peptides , 2005 .

[12]  M. Spannagl,et al.  Point-of-Care Analyse des Hämostasesystems , 2002 .

[13]  H. Wisser,et al.  Die Qualität diagnostischer Proben , 2002 .

[14]  G. Krieger Gebührenordnung für Ärzte — GOÄ , 1988 .

[15]  C. Price,et al.  A multicentre study of the new Reflotron system for the measurement of urea, glucose, triacylglycerols, cholesterol, gamma-glutamyltransferase and haemoglobin. , 1988, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[16]  Sverre Sandberg,et al.  Between-lot variation in external quality assessment of glucose: clinical importance and effect on participant performance evaluation. , 2005, Clinical chemistry.